When should a blood draw be performed relative to the application of testosterone topical cream to obtain an accurate trough level?

Blood Draw Timing for Testosterone Topical Cream

For testosterone topical cream or gel, perform the blood draw in the morning before the next application (trough level), ideally at least 14 days after starting treatment or any dose adjustment.

Timing Recommendations Based on Formulation

The timing of blood draws for testosterone monitoring depends critically on the specific formulation being used:

For Testosterone Gels/Creams (Non-Scrotal Application)

Blood should be drawn as a pre-dose morning trough level - meaning before the patient applies their next dose 1. The FDA labeling for testosterone gel 1.62% specifically instructs that dose titration should be based on "pre-dose morning serum testosterone concentration" obtained at approximately 14 days and 28 days after starting treatment or following dose adjustment 1.

• Key timing: Morning, fasting, before application
• When to check: At 14 days and 28 days after initiation or dose change, then periodically thereafter 1
• Rationale: Unlike injections which have predictable peaks and troughs, transdermal preparations can be measured "at any time" according to guidelines, though testosterone concentrations can vary substantially with gel use 2

For Testosterone Patches

Guidelines note that peak values occur 6 to 8 hours after application 2. However, for monitoring purposes, the same pre-dose morning approach is recommended for consistency.

For Scrotal Testosterone Cream (Special Case)

If the cream is being applied to scrotal skin specifically, the pharmacokinetics differ substantially:

• Peak serum testosterone occurs at 1.9-2.8 hours after application 3
• Therapeutic levels are reached within 2 hours and remain consistent beyond 6 hours 4
• For trough levels, draw before the next application

Critical Timing Considerations

Morning collection is essential because:

1. Testosterone exhibits diurnal variation with peak values in the morning 5
2. Fasting state is preferred as glucose and food intake suppress testosterone concentrations 5
3. Consistency in timing allows for accurate dose titration

The 14-day and 28-day checkpoints are specifically mandated by FDA labeling to ensure proper dose adjustment before steady-state complications develop 1.

Common Pitfalls to Avoid

• Don't draw blood at random times during the day - this introduces unnecessary variability and makes dose adjustments unreliable
• Don't check too early - wait at least 14 days after starting or changing dose to allow for steady-state levels 1
• Don't forget to confirm the application site - absorption varies significantly by site (arms/shoulders > chest/abdomen > legs) 6, 7, which affects interpretation
• Avoid drawing after washing - patients should avoid swimming/showering for minimum 2 hours after application 1, but for blood draws, ensure they haven't washed the application site immediately before (though this is less relevant for trough levels)

Practical Algorithm

1. Initial monitoring: Draw at 14 days and 28 days after starting therapy 1
2. Timing: Morning (8-10 AM), fasting, before next application 5
3. Target range: Adjust dose to keep pre-dose levels between 350-750 ng/dL 1
4. Ongoing monitoring: Every 6-12 months once stable 2

The pre-dose trough approach provides the most clinically useful information for dose titration and ensures patient safety by avoiding supraphysiologic peaks while confirming adequate trough coverage.